LFST LifeStance (LFST) Q2 FY26 earnings call
LifeStance Health delivered another strong quarter, surpassing guidance with robust revenue growth and significant adjusted EBITDA margin expansion, driven by increased clinician productivity and effective payer contracting. The company is strategically investing in technology, specialty services, and geographic expansion via tuck-in acquisitions, while preparing for a new EHR rollout in 2027. Management emphasizes its commitment to clinical outcomes and maintaining constructive payer relationships, positioning for sustained long-term growth despite near-term investment impacts.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
LFST operating KPIs by quarter
| KPI | Dec 2025 Q4 FY25 | This call Jun 2026 Q2 FY26 | Change vs prior quarter |
|---|---|---|---|
| Employees Clinicians | 8,040We grew our net clinicians by 44 in the fourth quarter and 657 for the full year, bringing our total clinician base to 8,040, representing growth of 9% year-over-year.Source: earnings call transcript | 8,542This was achieved while at the same time adding 193 clinicians in the second quarter, bringing our total clinician base to 8,542, representing growth of 11%.Source: earnings call transcript | +6.2% |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.